We are live on
!
Find out more
NC
Noked Capital Portfolio holdings
AUM
$946K
1-Year Est. Return
17.1%
This Fund
S&P 500
This Quarter
Est. Return
-14.26%
1 Year Est. Return
-17.1%
3 Year Est. Return
+197.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$119M
AUM Growth
–
Cap. Flow
+$135M
Cap. Flow
% of AUM
112.79%
Top 10 Holdings %
Top 10 Hldgs %
74.79%
Holding
57
New
57
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$29.5M |
| 2 |
Ituran Location and Control
ITRN
|
+$15.7M |
| 3 |
Caesarstone
CSTE
|
+$12.8M |
| 4 |
SolarEdge
SEDG
|
+$9.2M |
| 5 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$8.26M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.1% |
| 2 | Healthcare | 25.26% |
| 3 | Industrials | 12.43% |
| 4 | Energy | 6.89% |
| 5 | Financials | 5.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Teva Pharmaceuticals
TEVA
$40.2B
| $22.2M | 18.59% |
+1,439,275
| New | +$29.5M |
|
|
2
Ituran Location and Control
ITRN
$1.1B
| $14.9M | 12.52% |
+466,051
| New | +$15.7M |
|
|
3
Caesarstone
CSTE
$75.4M
| $11.2M | 9.36% |
+822,408
| New | +$12.8M |
|
|
MLNX
4
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $8.98M | 7.52% |
+97,200
| New | +$8.26M |
|
|
5
SolarEdge
SEDG
$2.74B
| $8.43M | 7.06% |
+240,193
| New | +$9.2M |
|
6
Delek US
DK
$4.05B
| $6.68M | 5.59% |
+205,400
| New | +$7.77M |
|
7
iShares MSCI ACWI ETF
ACWI
$32.8B
| $6.22M | 5.21% |
+97,000
| New | +$6.66M |
|
8
Viatris
VTRS
$20.5B
| $4.64M | 3.89% |
+169,395
| New | +$5.49M |
|
|
MSGN
9
DELISTED
MSG Networks Inc.
MSGN
| $3.28M | 2.75% |
+139,400
| New | +$3.56M |
|
10
Lindblad Expeditions
LIND
$2.17B
| $2.74M | 2.3% |
+203,900
| New | +$2.72M |
|
11
Apple
AAPL
$4.46T
| $1.92M | 1.61% |
+48,700
| New | +$2.36M |
|
12
Microsoft
MSFT
$3.62T
| $1.65M | 1.38% |
+16,200
| New | +$1.74M |
|
13
Hershey
HSY
$35.7B
| $965K | 0.81% |
+9,000
| New | +$957K |
|
14
Biogen
BIIB
$29.8B
| $903K | 0.76% |
+3,000
| New | +$957K |
|
15
PepsiCo
PEP
$191B
| $884K | 0.74% |
+8,000
| New | +$902K |
|
16
Chevron
CVX
$385B
| $870K | 0.73% |
+8,000
| New | +$927K |
|
17
HP
HPQ
$24.8B
| $859K | 0.72% |
+42,000
| New | +$980K |
|
18
HSBC
HSBC
$370B
| $822K | 0.69% |
+20,744
| New | +$831K |
|
19
Intel
INTC
$459B
| $798K | 0.67% |
+17,000
| New | +$796K |
|
20
Elevance Health
ELV
$83B
| $788K | 0.66% |
+3,000
| New | +$825K |
|
21
Alphabet (Google) Class A
GOOGL
$4.57T
| $784K | 0.66% |
+15,000
| New | +$811K |
|
22
ManpowerGroup
MAN
$2.52B
| $778K | 0.65% |
+12,000
| New | +$912K |
|
23
US Bancorp
USB
$99.6B
| $777K | 0.65% |
+17,000
| New | +$875K |
|
24
Chubb
CB
$134B
| $775K | 0.65% |
+6,000
| New | +$775K |
|
25
American Express
AXP
$233B
| $763K | 0.64% |
+8,000
| New | +$837K |
|
Similar funds
MC
GAM
NP
TGI
IVAV
VM
SC
CL
Noked Capital's Q4 2018 Portfolio in Review
Q4 2018 is the first quarter with a 13F filing on record for Noked Capital, which disclosed 57 positions worth $119M. Its ten largest holdings account for 75% of the portfolio.
Its largest position is Teva Pharmaceuticals: 1,439,275 shares worth $22.2M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, followed by Healthcare and Industrials.
- Noked Capital's largest Q4 2018 buy was Teva Pharmaceuticals: 1,439,275 shares worth $22.2M.
- Noked Capital's ten largest holdings make up 75% of its $119M portfolio in Q4 2018.
- Noked Capital disclosed 57 positions in Q4 2018, its first 13F filing on record.
Based on Noked Capital's 13F filing for Q4 2018, filed 12 Feb 2019.